Skip to main content
. 2021 Nov 2;12:721409. doi: 10.3389/fimmu.2021.721409

Figure 4.

Figure 4

Determination of melanoma mutational signatures and their sex biases with respect to ICI efficacy. (A) Heatmap representation of the cosine similarities between the extracted four mutational signatures and 30 COSMIC signatures. (B) Identification of the four mutational signatures with specific etiology according to the COSMIC nomenclature. (C) Distinct activities of the identified four mutational signatures between male and female subgroups. (D) Kaplan–Meier survival curves stratified by signature 4 status in male melanoma patients. Forest plot illustration of the associations of signature 4 with ICI overall survival in (E) male and (F) female patients. Bar plots representation of the associations of signature 4 with ICI response rate in (G) male and (H) female patients. **P < 0.01; ***P < 0.001; NS, not significant.